Evidence map›Paper›PMID 23302687›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Discovery of indolotryptoline antiproliferative agents by homology-guided metagenomic screening.

Fang-Yuan Chang, Sean F Brady

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 112 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Comprehensive genome analysis of two novelFrontiers in microbiology · 2024
    Article
  11. Article
  12. Naturally Occurring Organohalogen Compounds-A Comprehensive Review.Progress in the chemistry of organic natural products · 2023
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Heterologous expression-facilitated natural products' discovery in actinomycetes.Journal of industrial microbiology & biotechnology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Fang-Yuan ChangLaboratory of Genetically Encoded Small Molecules, Howard Hughes Medical Institute, The Rockefeller University, New York, NY 10065, USA.
Sean F Brady
Howard Hughes Medical Institute · US

Funding

Discovery and characterization of new natural products from uncultured bacteriaR01GM077516 · NIGMS · ROCKEFELLER UNIVERSITY · PI BRADY, SEAN F · 2006 to 2014
$3.0M
Howard Hughes Medical InstituteNIGMS NIH HHS GM077516NIGMS NIH HHS R01 GM077516
6 · The paper itself

Abstract

Natural product discovery by random screening of broth extracts derived from cultured bacteria often suffers from high rates of redundant isolation, making it ever more challenging to identify novel biologically interesting natural products. Here we show that homology-based screening of soil metagenomes can be used to specifically target the discovery of new members of traditionally rare, biomedically relevant natural product families. Phylogenetic analysis of oxy-tryptophan dimerization gene homologs found within a large soil DNA library enabled the identification and recovery of a unique tryptophan dimerization biosynthetic gene cluster, which we have termed the bor cluster. When heterologously expressed in Streptomyces albus, this cluster produced an indolotryptoline antiproliferative agent with CaMKIIδ kinase inhibitory activity (borregomycin A), along with several dihydroxyindolocarbazole anticancer/antibiotics (borregomycins B-D). Similar homology-based screening of large environmental DNA libraries is likely to permit the directed discovery of new members within other previously rare families of bioactive natural products.

Indexed as

Phylogeny5-HydroxytryptophanBase SequenceBiological ProductsBiosynthetic PathwaysCarbolinesDimerizationDNA PrimersDrug DiscoveryGene LibraryGenetic TestingMass SpectrometryMetagenomeMolecular Sequence DataMolecular StructureMultigene Family5-HydroxytryptophanBiological Productscalmodulin dependent protein kinase II phosphataseCarbolinesDNA PrimersPhosphoprotein PhosphatasesSoiltryptoline

Identifiers

PMID23302687
PMCPMC3574908
OpenAlexW2090199399

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.